Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patientsGalatea Kallergi, Sofia Agelaki|Breast Cancer Research|2011Cited by 373
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Jean‐Yves Pierga et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerGiannis Mountzios, Petros Christopoulos, Mariam Elshiaty et al.|ESMO Open|2021Cited by 93
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast CancerMaria A. Papadaki, Sofia Agelaki|Cancers|2020Cited by 88
Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast CancerSofia Agelaki, Vassilis Georgoulias|PLoS ONE|2015Cited by 58